| Tag | Content |
|---|
EnhancerAtlas ID | HS155-03209 |
Organism | Homo sapiens |
Tissue/cell | Ovary |
Coordinate | chr12:13144920-13145990 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr12:13145885-13145906 | ATGGTGAAACTGAAACAAAAA | - | 6.81 | | Nfe2l2 | MA0150.2 | chr12:13145562-13145577 | TGCTGAATCATTCTG | - | 6.78 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_46589 | chr12:13143937-13147247 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr12 | 13145446 | 13145954 | | chr12 | 13145478 | 13145960 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I012990 | chr12 | 13143372 | 13147333 |
|
Enhancer Sequence | AAGGTGCTGT GTCTCCTAAC AATGATTATG AAAAACAGAC ACATGGTAGG GAACCTGGCT 60
GCCCTAGACT GGTCAAATAG GTTTTCATAT AATATCCTAG ACTGAAGATT CACAACTAGG 120
GAAGAGGGTG TGACTCCCAG GGGGACAGAA GGTGTCTCTG GAGGAAGGCA GGACTGTACG 180
GCTGTGAGTG GCAAGTGTAG TCTCAATGAG CATATTTAAT ATTTATTTTA TTTTTGAGAC 240
AGAGTCTTGC TCTGTCACCC GGGCTGGAGT GCAGTGGTGT GATCTCTGCT AAGAGCAACC 300
TTCACCCCCC AGGTTCAAGT GATTCTTCTG CCTCAGCCTC ACAAGTAGCT GAGACTACAG 360
GCGAACGCCA CCACTCCCAG CTAATTTTTG TGTTTTTAGT AGAGATGGGG TTTTGCCACA 420
TTGGACAGAC TGGTCTCGAA CTCCTGACCT CAGGTGTTCT GCCCACCTCG GCCTCCCAAA 480
GTGCTGGGAT TACAGGTATG AGCCACTGTG CCCGGCCTTA ATATTGTAAT TTTAACCCTG 540
AGTGCCAAGT TTGTACTTAA ATCCCCCTTC ACATGGGGTA GAGGAAATTG CGCCAGACCA 600
GGAATCATGA GGCAGCAAGT CAGCCTTGAC TGTGGGGCAC CGTGCTGAAT CATTCTGAGG 660
CTGCTGTGAA GCCCTCCATC TGGTGAATCT GACACTTCCA AAGAGCCTTC AGTAGCAAAC 720
TGTTAAGTAA ACTTAGGGTG TTTTGCTCTT TCTGTTGCTG CAGAGAATTC CAGAACTCCC 780
CTTTCATTTG AGAGCGCACC TACCCTTGGC ACTTGTAATG TTTTAAATTC CAGAAACACT 840
ATCCTGTGAA TCACAGAAGT TCAGAACCTA AAATGGTTTT AAAGTTTACC TAATCTAACT 900
AATTTTATCA AGGAGAAAAT GAAGAACCAG AGAGACTAAG TTGCTCAAAG TGATGTAACT 960
ACTGAATGGT GAAACTGAAA CAAAAATTCC AGTTCCCAAA CTCTAGTCTA CTCCAGTCTA 1020
ATACTCGTTG CAAGGTTCTC TAAAGCTATG GGGGGTGAAG TGAGCATTTA 1070
|
